These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29667340)

  • 1. Erasmus syndrome: systemic sclerosis and silicosis co-occurrence.
    Sarı Sürmelİ Z; Oruçoğlu N
    Int J Rheum Dis; 2018 Jun; 21(6):1326-1329. PubMed ID: 29667340
    [No Abstract]   [Full Text] [Related]  

  • 2. Moyamoya disease and systemic sclerosis (MoSys syndrome): a combination of two rare entities.
    Wegner F; Mueller-Ladner U; Meier FM
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):210. PubMed ID: 27606722
    [No Abstract]   [Full Text] [Related]  

  • 3. Erasmus syndrome: silicosis and systemic sclerosis.
    de Miranda AA; Nascimento AC; Peixoto IL; Scrignoli JA; Cardoso Mdo S; Ribeiro SL
    Rev Bras Reumatol; 2013; 53(3):310-3. PubMed ID: 24051915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recent advances in diagnosis and treatment of connective tissue diseases].
    Lorenz HM
    Dtsch Med Wochenschr; 2011 Apr; 136(14):710-2. PubMed ID: 21448833
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diagnostic case: Erasmus syndrome associating silica exposure with silicosis and systemic sclerosis].
    Paret M; Cottin V; Loubeyre P; Philit F; Revel D; Cordier JF
    J Radiol; 1995 Dec; 76(12):1127-8. PubMed ID: 8676307
    [No Abstract]   [Full Text] [Related]  

  • 6. Trigeminal neuropathy responding to systemic corticosteroids and methotrexate in a patient with diffuse cutaneous systemic sclerosis.
    Miguel D; Darr-Foit S; Tittelbach J; Elsner P
    Eur J Dermatol; 2017 Feb; 27(1):82-83. PubMed ID: 27748258
    [No Abstract]   [Full Text] [Related]  

  • 7. Erasmus Syndrome: An Underrecognized Entity.
    Magalhães A; Moreira I; Pinheiro S; Borba A
    Acta Med Port; 2023 Feb; 36(2):122-126. PubMed ID: 35549794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arthritis Mutilans in Systemic Sclerosis.
    Abignano G; Mennillo GA; Lettieri G; Padula A; McGonagle D; D'Angelo S
    Arthritis Rheumatol; 2019 Jan; 71(1):120. PubMed ID: 30221850
    [No Abstract]   [Full Text] [Related]  

  • 9. Protective role of interleukin-6 in systemic sclerosis gastrointestinal tract involvement: case report and review of the literature.
    Frech TM; Hudson M
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S179-81. PubMed ID: 26339896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erasmus syndrome: The association of systemic sclerosis and silicosis.
    Osejo-Betancourt M; Chaparro-Mutiz P
    Monaldi Arch Chest Dis; 2022 Apr; 93(1):. PubMed ID: 35416002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse systemic sclerosis and autoimmune hepatitis: a unique association.
    Rodrigues CE; Borges CL; de Carvalho JF
    Clin Rheumatol; 2010 Jul; 29(7):799-801. PubMed ID: 20140473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible posterior leukoencephalopathy in diffuse scleroderma.
    Piñol NC; Villarino MR; Narvaez JA; Narvaez J
    Clin Exp Rheumatol; 2010; 28(2 Suppl 58):63-4. PubMed ID: 20576217
    [No Abstract]   [Full Text] [Related]  

  • 13. [Erasmus syndrome: clinical, tomographic, respiratory function and bronchoalveolar lavage characteristics].
    Cointrel C; Tillie-Leblond I; Lamblin C; Furon D; Tonnel AB; Wallaert B
    Rev Mal Respir; 1997 Jan; 14(1):21-6. PubMed ID: 9082502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erasmus Syndrome: A Case Report and Literature Review.
    Lomanta JMJ; Atienza MA; Gonzales JRM; Amante EJB; Urquiza SC; Lucero-Orillaza H; Santiaguel JM
    Am J Case Rep; 2022 Aug; 23():e937061. PubMed ID: 35947536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Erasmus syndrome: case report].
    Ajlani H; Meddeb N; Sahli H; Sellami S
    Rev Pneumol Clin; 2009 Feb; 65(1):16-22. PubMed ID: 19306779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The association: scleroderma-silicosis or Erasmus' syndrome (author's transl)].
    Devulder B; Plouvier B; Martin JC; Lenoir L
    Nouv Presse Med; 1977 Oct; 6(32):2877-9. PubMed ID: 917805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful control of scleroderma myocarditis using a combination of cyclophosphamide and methylprednisolone.
    Stack J; McLaughlin P; Sinnot C; Henry M; MacEneaney P; Eltahir A; Harney S
    Scand J Rheumatol; 2010 Aug; 39(4):349-50. PubMed ID: 20476869
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of early diffuse systemic sclerosis skin disease.
    Frech TM; Shanmugam VK; Shah AA; Assassi S; Gordon JK; Hant FN; Hinchcliff ME; Steen V; Khanna D; Kayser C; Domsic RT
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):166-71. PubMed ID: 23910619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy and tolerability of mycophenolate mofetil therapy in diffuse scleroderma skin disease.
    Boulos D; Ngian GS; Rajadurai A; Elford K; Stevens W; Proudman S; Owen C; Roddy J; Nikpour M; Youssef P; Hill C; Sahhar J
    Int J Rheum Dis; 2017 Apr; 20(4):481-488. PubMed ID: 28337853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silent myocarditis in systemic sclerosis detected by cardiovascular magnetic resonance using Lake Louise criteria.
    Mavrogeni S; Koutsogeorgopoulou L; Karabela G; Stavropoulos E; Katsifis G; Raftakis J; Plastiras S; Noutsias M; Markousis-Mavrogenis G; Kolovou G
    BMC Cardiovasc Disord; 2017 Jul; 17(1):187. PubMed ID: 28716007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.